AGLE · Categories · Form 3

AGLE - SEC Form 3 initial insider statements

Aeglea BioTherapeutics Inc. (AGLE) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for AGLE

• 849d
  SEC Form 3 filed by new insider Mckenna Mark C.

  3 - Spyre Therapeutics, Inc. (0001636282) (Issuer)
• 908d
  SEC Form 3 filed by new insider Albers Jeffrey W. (Amendment)

  3/A - Spyre Therapeutics, Inc. (0001636282) (Issuer)
• 919d
  SEC Form 3 filed by new insider Albers Jeffrey W.

  3 - Spyre Therapeutics, Inc. (0001636282) (Issuer)
• 919d
  SEC Form 3 filed by new insider Stelzer Laurie

  3 - Spyre Therapeutics, Inc. (0001636282) (Issuer)
• 1002d
  SEC Form 3 filed by new insider King-Jones Heidy

  3 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1002d
  SEC Form 3 filed by new insider Burrows Scott L

  3 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1069d
  SEC Form 3: New insider Fairmount Funds Management Llc claimed ownership of 9,460,540 shares

  3 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1069d
  SEC Form 3: New insider Turtle Cameron claimed ownership of 576,699 shares

  3 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1069d
  SEC Form 3 filed by new insider Henderson Michael Thomas

  3 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1223d
  SEC Form 3: New insider Neuman Linda L claimed ownership of 4,000 shares

  3 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1280d
  SEC Form 3 filed by new insider Goldberg Jeff Marc

  3 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1378d
  SEC Form 3: New insider Kastenmayer James Paul claimed ownership of 4,000 shares

  3 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1660d
  SEC Form 3 filed by new insider Smith Hunter C

  3 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1791d
  SEC Form 3 filed by Alspaugh Jonathan

  3 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1807d
  SEC Form 3 filed by Souza Marcio

  3 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1924d
  SEC Form 3: Lp Advisors Bros. Baker claimed ownership of 3,410,106 units of Common Stock

  3 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1924d
  SEC Form 3 filed by Sara Brownstein

  3 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1941d
  SEC Form 3: Steven Weber claimed ownership of 17,652 units of Common Stock

  3 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)

Other AGLE categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends